It's been an eventful year in the world, and if it seems like it's been a bumpy ride for your...
Medical
AimThe aim of the study is to determine how gender patterns of adolescent mental health solely based on symptoms are...
Myriad Genetics (NASDAQ: MYGN) has announced a collaboration with Flatiron Health to integrate its MyRisk®...
Researchers at the University of Minnesota are planning to explore everything from experimental new medications to exercise regimens to see...
Myriad Genetics, Inc.Myriad’s MyRisk® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR®SALT LAKE CITY, Oct. 15, 2024 (GLOBE...